VBI Vaccines (VBIV) Announces Positive Outcome from Phase III Pre-IND Discussions with FDA for Hepatitis B Vaccine, Sci-B-Vac
Tweet Send to a Friend
VBI Vaccines Inc. (NASDAQ: VBIV) announced today that it has completed a pre-Investigational New Drug ("IND") meeting with the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
